Biphasic effect of acamprosate on NMDA but not on GABAA receptors in spontaneous rhythmic activity from the isolated neonatal rat respiratory network

Autor: Olivier Pierrefiche, Mickaël Naassila, Martine Daoust
Přispěvatelé: Groupe de Recherche sur l'alcool et les pharmacodépendances - UMR INSERM_S 1247 (GRAP), Université de Picardie Jules Verne (UPJV)-Institut National de la Santé et de la Recherche Médicale (INSERM), Naassila, Mickael
Jazyk: angličtina
Rok vydání: 2004
Předmět:
Aging
Hypoglossal Nerve
N-Methylaspartate
MESH: Rats
Taurine
Acamprosate
MESH: Alcohol Deterrents
MESH: Rats
Sprague-Dawley

Pharmacology
Inhibitory postsynaptic potential
Receptors
N-Methyl-D-Aspartate

MESH: Animals
Newborn

Rats
Sprague-Dawley

03 medical and health sciences
Cellular and Molecular Neuroscience
0302 clinical medicine
medicine
Animals
MESH: Aging
MESH: Animals
[SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]
Receptor
MESH: Receptors
GABA-A

030304 developmental biology
0303 health sciences
MESH: Receptors
N-Methyl-D-Aspartate

Chemistry
GABAA receptor
Receptors
GABA-A

3. Good health
Rats
MESH: Taurine
MESH: N-Methylaspartate
Mechanism of action
Animals
Newborn

nervous system
MESH: Hypoglossal Nerve
Excitatory postsynaptic potential
Respiratory Mechanics
NMDA receptor
MESH: Respiratory Mechanics
[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]
Brainstem
medicine.symptom
030217 neurology & neurosurgery
medicine.drug
Alcohol Deterrents
Zdroj: Neuropharmacology
Neuropharmacology, Elsevier, 2004, 47 (1), pp.35-45. ⟨10.1016/j.neuropharm.2004.03.004⟩
Neuropharmacology, 2004, 47 (1), pp.35-45. ⟨10.1016/j.neuropharm.2004.03.004⟩
ISSN: 0028-3908
DOI: 10.1016/j.neuropharm.2004.03.004⟩
Popis: International audience; Acamprosate (calcium acetylhomotaurinate) has been shown to be effective in attenuating relapse in human alcoholics. The precise mechanism for acamprosate has been yet to be determined as there may be multiple sites of action for this drug. We investigated the mechanism of action of acamprosate on a spontaneous rhythmic activity recorded from hypoglossal nerve rootlet (XII) in neonatal rat brainstem slices. At 30 microM, acamprosate reversibly increased burst amplitude and reduced burst frequency, whereas at higher concentrations (100-400 microM) it induced a reversible and concentration-dependent inhibition of this activity. Interestingly, acamprosate (30 microM) enhanced the effects of low NMDA-induced excitation (1.5 microM), but inhibited higher NMDA-induced excitation (2.5, 5 microM) by 50-70%, demonstrating a differential effect on NMDA-induced excitation. Blockade of GABAA receptors did not affect the increase in amplitude of 30 microM acamprosate and partially abolished the inhibitory effects of 200 microM acamprosate. At 200 microM, acamprosate reduced high NMDA-induced excitation and abolished NMDA-evoked excitatory tonic phase, suggesting that excitatory effect of low concentrations of acamprosate mainly involved NMDA receptors, while the inhibitory effects at higher concentration included an increase in GABAA-mediated inhibition with a reduction of NMDA-mediated excitation. Consequently, combined blockade of both receptors abolished all effects of acamprosate tested at all concentrations. These results show that the effects of acamprosate are mediated via both GABAA and NMDA receptors and suggest a partial co-agonist role on NMDA receptors, at the level of a spontaneously active network.
Databáze: OpenAIRE